The metabolic anatomy of tremor in Parkinson's disease

Neurology

Volumn 51, Issue 3, 1998, Pages 803-810

  Antonini, A ^a   Moeller, J R ^b,c   Nakamura, T ^a   Spetsieris, P ^a   Dhawan, V ^a   Eidelberg, D ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NERVE CELL NETWORK; NEUROMODULATION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; TREMOR;

EID: 0031722261     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.3.803     Document Type: Article

References (42)

1. Moeller JR, Strother SC, Sidtis JJ, Rottenberg DA. The scaled subprofile model: a statistical approach to the analysis of functional patterns in positron emission tomographic data. J Cereb Blood Flow Metab 1987;7:649-658.
2. Alexander GE, Moeller JR. Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders: a principal component approach to modeling brain function in disease. Hum Brain Map 1994;2:1-16.
3. 18F-fluorodopa positron emission tomography studies. Mov Disord 1990;5:203-210.
4. Eidelberg D, Moeller JR, Dhawan V, et al. The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 1994; 14:783-801.
5. Eidelberg D, Moeller JR, Kazumata K, et al. Metabolic correlates of pallidal neuronal activity in Parkinson's disease. Brain 1997;120:1315-1324.
6. 18F-fluorodeoxyglucose and positron emission tomography. J Nucl Med 1995;36:378-383.
7. 18F-fluorodeoxyglucose and positron emission tomography. Neurology 1995;45:1995-2004.
8. Moeller JR, Ishikawa T, Dhawan V, et al. The metabolic topography of normal aging. J Cereb Blood Flow Metab 1996;16: 385-398.
9. Eidelberg D, Moeller JR, Dhawan V, et al. Reproducibility of regional metabolic covariance patterns: comparison of four populations. In: Carson R, Daube-Witherspoon M, Herscovitch P, eds. Quantitative functional brain imaging with positron emission tomography. San Diego: Academic Press, 1998.
10. Moeller JR, Eidelberg D. Divergent expression of regional metabolic topographies in Parkinson's disease and normal aging. Brain 1997;120:2197-2206.
11. Lenz FA, Tasker RR, Schnider S, et al. Single-unit analysis of the human ventral thalamic nuclear group: correlation of thalamic "tremor cells" with the 3-6 Hz component of parkinsonian tremor. J Neurosci 1988;8:754-764.
12. Paré D, Curro'Dossi R, Stereiade M. Neuronal basis of the parkinsonian resting tremor: a hypothesis and its implications for treatment. Neuroscience 1990;35:217-226.
13. Taha JM, Jacques F, Baumann TK, Burchiel KJ. Tremor control after pallidotomy in patients with Parkinson's disease: correlation with microrecording findings. J Neurosurg 1997; 86:642-647.
14. Fahn S. Idiopathic torsion dystonia. In: Calne DB, ed. Neurodegenerative diseases. Philadelphia: W.B. Saunders, 1994: 705-715.
15. DeGrado TR, Turkington TG, Williams JJ, et al. Performance characteristics of a whole-body PET scanner. J Nucl Med 1994;35:1398-1406.
16. Hariz MI, Eriksson AT. Reproducibility of repeated mountings of a noninvasive CT/MRI stereoadapter. Appl Neurophysiol 1986;49:336-347.
17. 18F-2-fluoro-2-deoxy-D-glucose. Validation of method. Ann Neurol 1979;6:371-388.
18. Takikawa S, Dhawan V, Robeson W, et al. Noninvasive quantitative FDG-PET studies using an estimated input function derived from a population arterial blood curve. Radiology 1993;188:131-136.
19. Spetsieris P, Dhawan V, Takikawa S, et al. Imaging cerebral function. IEEE/Comput Graph Appl 1993;13:15-26.
20. Talairach J, Tournoux P. Coplanar stereotaxic atlas of the human brain. New York: Thieme Medical Publishers, 1988.
21. 18F-fluorodeoxyglucose positron emission tomographic region-of-interest data. J Cereb Blood Flow Metab 1991;11:A83-A88.
22. Winer BJ. Statistical principles in experimental design. New York: McGraw-Hill, 1971.
23. Alexander GE, Crutcher MD, DeLong MR. Basal gangliathalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 1990;85:119-146.
24. Fox MW, Ahlskog JE, Kelly PJ. Stereotactic ventrolateralis pallidotomy for medically refractory tremor in post-levodopa era in Parkinson's disease patients. J Neurosurg 1991;75:723-730.
25. Burchiel KJ. Thalamotomy for movement disorders. Funct Neurosurg 1995;6:55-71.
26. Blond S, Siegfried J. Thalamic stimulation for the treatment of tremor and other movement disorders. Acta Neuroschirurgica 1991;52:109-111.
27. Benabid AL, Pollak P, Seigneuret E, et al. Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extrapyramidal dyskinesias. Acta Neurochir 1993;58:39-44.
28. Parker F, Tzourio N, Blond S, Petit H, Mazoyer B. Evidence for a common network of brain structures involved in Parkinsonian tremor and voluntary repetitive movement. Brain Res 1992;584:11-17.
29. Duffau H, Tzourio N, Caparros-Lefebvre D, Parker F, Mazoyer B. Tremor and voluntary repetitive movement in Parkinson's disease: comparison before and after L-dopa with positron emission tomography. Exp Brain Res 1996;107:452-462.
30. Parent A, Hazrati LN. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Reviews 1995;20:91-127.
31. 15O/PET motor activation study. Ann Neurol 1997;41:108-111.
32. Logigian E, Hefter H, Reiners K, Freund HJ. Does tremor pace repetitive voluntary behavior in Parkinson's disease? Ann Neurol 1991;30:172-179.
33. Mäkelä JP, Hari R, Karhu J, Salmelin R, Teräväinen H. Suppression of magnetic μ rhythm during parkinsonian tremor. Brain Res 1993;617:189-193.
34. Volkmann J, Joliet M, Mogilner, et al. Central motor look oscillations in parkinsonian resting tremor revealed by magnetoencephalography. Neurology 1996;46:1359-1370.
35. Zetusky WJ, Jankovic J, Pirozzolo FJ. The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology 1985;35:522-526.
36. Martinez-Martin P, Gil-Nagel A, Morlan Gracia L, et al. Unified Parkinson's Disease Rating Scale characteristics and structure. Mov Disord 1994;9:76-83.
37. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140-148.
38. McDermott MP, Jankovic J, Carter J, et al. Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. Arch Neurol 1995;52:565-570.
39. Filion M. Effects of interruption of the nigrostriatal pathway and of dopaminergic agents on the spontaneous activity of globus pallidus neurons in the awake monkey. Brain Res 1979;178:425-441.
40. Boecker H, Weindl A, Leenders KL, et al. Secondary parkinsonism due to focal substantia nigra lesions: regional cerebral glucose utilization and dopa-decarboxylase studied using PET. Acta Neurol Scand 1996;93:387-392.
41. Filion M, Tremblay L, Bedard P. Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991;547: 152-161.
42. Deiber M, Pollak P, Passingham R, et al. Thalamic stimulation and suppression of parkisonian tremor. Brain 1993;116: 267-279.